PLIANT THERAPEUTICS INC (PLRX) Stock Analyst Ratings
NASDAQ:PLRX - Nasdaq - US7291391057 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 69% to PLRX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.88. This target is 214.93% above the current price.
PLRX was analyzed by 19 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about PLRX.
In the last month the buy percentage fell by 7 points. So the trust of analysts is decreasing.
PLRX was analyzed by 19 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-18 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-04 | Cantor Fitzgerald | Reiterate | Neutral |
| 2025-03-04 | Needham | Downgrade | Buy -> Hold |
| 2025-03-04 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2025-03-04 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-04 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-03-04 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-03-03 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2025-02-14 | Needham | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-10 | Needham | Maintains | Buy -> Buy |
| 2025-02-10 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2025-02-10 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-02-10 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-02-10 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2025-02-10 | Citigroup | Downgrade | Buy -> Neutral |
| 2025-02-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-08 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-08-08 | Needham | Reiterate | Buy -> Buy |
| 2024-08-08 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-07-16 | Needham | Reiterate | Buy -> Buy |
| 2024-07-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-07 | Needham | Reiterate | Buy -> Buy |
| 2024-05-07 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-07 | RBC Capital | Maintains | Outperform -> Outperform |